🚀 June’s AI-picked stocks soar, with Adobe +18.1% in 11 days. Don’t miss July’s upcoming picks.Unlock full list

EURO: Will ECB Follow In BoC's Footsteps?

Published 21/04/2021, 18:25
EUR/USD
-
USD/CAD
-
JNJ
-
Thursday’s European Central Bank monetary policy announcement is one of the most important event risks this week. With a seven-week gap between tomorrow’s meeting and the next, the ECB has one of two choices – it can take this opportunity to clarify its forward guidance or it can keep its assessment unchanged and bide its time until there is clearer evidence that European nations have gotten the third virus wave under control. 
 
The Bank of Canada chose the former. It left interest rates unchanged but tapered asset purchases by $1 billion and drew forward its rate hike forecast. Previously, the central bank did not expect to raise rates before 2023. Now, it sees no rate hike until the second half of 2022. Like the Eurozone, Canada is experiencing sharp rises in COVID-19 cases, with stay-at-home measures in many provinces. However, with a strong local jobs market and the U.S. economy recovering quickly, the BoC believes the COVID-19 pandemic will be less detrimental to the economy’s output than previously expected. It now sees the economy growing 6.5% this year, up from a prior forecast of 4%. The Canadian dollar soared after the rate decision, with USD/CAD dropping more than 150 pips intraday.
 
The Canadian dollar’s reaction to the BoC announcement could be a precursor of what the euro trades can expect tomorrow. From a data perspective, most economic reports haven’t been terrible. The Eurozone economy fared better than analysts anticipated despite widespread lockdowns. A contraction is expected for many Eurozone nations this quarter, but judging from the rally in the euro this month, investors are not worried about a lasting impact. They shrugged off weaker German ZEW and IFO reports and could do the same with April PMIs, which are scheduled for release on Friday. We saw this last summer when the prospect of a recovery drove EUR/USD higher before restrictions were eased. 
 
Euro traders are usually very forward looking, and while the region’s vaccination rate lags far behind the U.S. and UK, every day, more and more of their population is getting vaccinated. The European Union resumed its usage of the Johnson & Johnson (NYSE:JNJ) vaccine, which should speed up the process. Europe is basically four to six weeks behind the U.S., which means it is only a matter of time before its recoveries gain momentum. The ECB knows this, and the big question tomorrow is whether it will acknowledge it. If the ECB expresses the same optimism as the BoC, EUR/USD could make a run for 1.21. If it remains cautious and suggests stimulus could increase, EUR/USD could test 1.19 with more significant losses for the euro against the crosses. 
Vaccination Rates In Europe.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.